We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$175B
$301M 0.55%
2,246,024
+461,093
+26% +$60.5M
LIN icon
27
Linde
LIN
$234B
$298M 0.54%
627,990
-53,273
-8% -$25.2M
BAC icon
28
Bank of America
BAC
$430B
$293M 0.53%
5,684,288
+296,826
+6% +$14.5M
CVX icon
29
Chevron
CVX
$387B
$278M 0.51%
1,793,014
+520,148
+41% +$80.6M
ADP icon
30
Automatic Data Processing
ADP
$97.1B
$267M 0.49%
909,673
-49,058
-5% -$14.8M
GE icon
31
GE Aerospace
GE
$362B
$258M 0.47%
858,989
+50,805
+6% +$13.9M
KO icon
32
Coca-Cola
KO
$349B
$257M 0.47%
3,869,664
+290,767
+8% +$20M
DHR icon
33
Danaher
DHR
$135B
$255M 0.46%
1,288,386
+441,296
+52% +$87.8M
UNH icon
34
UnitedHealth
UNH
$385B
$249M 0.45%
720,251
+35,325
+5% +$10.7M
MRK icon
35
Merck
MRK
$322B
$233M 0.42%
2,772,306
+88,567
+3% +$7.29M
TJX icon
36
TJX Companies
TJX
$170B
$224M 0.41%
1,550,082
+139,786
+10% +$18.6M
CSCO icon
37
Cisco
CSCO
$444B
$216M 0.39%
3,161,001
+182,168
+6% +$12.4M
WFC icon
38
Wells Fargo
WFC
$261B
$215M 0.39%
2,560,290
+122,306
+5% +$9.92M
IBM icon
39
IBM
IBM
$194B
$208M 0.38%
738,150
+44,898
+6% +$11.8M
AMD icon
40
Advanced Micro Devices
AMD
$880B
$208M 0.38%
1,285,758
+77,009
+6% +$12.4M
PEP icon
41
PepsiCo
PEP
$184B
$207M 0.38%
1,476,743
+66,116
+5% +$9.44M
TMO icon
42
Thermo Fisher Scientific
TMO
$213B
$204M 0.37%
421,207
-4,895
-1% -$2.28M
GS icon
43
Goldman Sachs
GS
$317B
$199M 0.36%
250,196
+14,899
+6% +$11M
CRM icon
44
Salesforce
CRM
$129B
$199M 0.36%
840,182
+44,278
+6% +$11.2M
TSM icon
45
TSMC
TSM
$2.16T
$199M 0.36%
711,577
+123,394
+21% +$30.2M
NXPI icon
46
NXP Semiconductors
NXPI
$70B
$196M 0.36%
860,223
+313,209
+57% +$70.4M
WAB icon
47
Wabtec
WAB
$50.3B
$192M 0.35%
958,483
+430,798
+82% +$85M
MRSH
48
Marsh
MRSH
$84.2B
$187M 0.34%
927,765
-152,419
-14% -$31.3M
CAT icon
49
Caterpillar
CAT
$412B
$183M 0.33%
384,172
+23,046
+6% +$9.84M
CL icon
50
Colgate-Palmolive
CL
$72.1B
$181M 0.33%
2,259,120
+310,248
+16% +$26.5M
1
2
3 4 5

Similar funds

Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.